[Goose]

https://www.prnewswire.com/news-releases...31785.html

Still an early result (phase 2), but encouraging nevertheless. If we can keep people out of the hospital with this kind of treatment we can tolerate a higher case load, and fewer people will die.

The cost of these drugs will likely make it impractical use them in mildly sick individuals.

Interesting, because that seems to be the patient population they are looking at, people who are positive within the last three days but not really sick yet. Seems that wouldn't make sense if this drug was going to be real expensive for exactly the reason you cite. It wouldn't be given to people who were not in great need if the cost is high.

Side effects are sometimes severe with MOABS as well.

True, but they are saying that so far at least they have no treatment-related SAEs. We will obviously have more data at the end of the study.

Whether they will do much for you once you are really sick is to be determined.

True, and this study isn't really targeting those individuals. This study is done on an outpatient basis, so you get the IV and go home. They are claiming pretty significant reductions in hospitalizations.

[Goose]

https://www.prnewswire.com/news-releases...31785.html

Still an early result (phase 2), but encouraging nevertheless. If we can keep people out of the hospital with this kind of treatment we can tolerate a higher case load, and fewer people will die.

The cost of these drugs will likely make it impractical use them in mildly sick individuals.

Interesting, because that seems to be the patient population they are looking at, people who are positive within the last three days but not really sick yet. Seems that wouldn't make sense if this drug was going to be real expensive for exactly the reason you cite. It wouldn't be given to people who were not in great need if the cost is high.

Side effects are sometimes severe with MOABS as well.

True, but they are saying that so far at least they have no treatment-related SAEs. We will obviously have more data at the end of the study.

Whether they will do much for you once you are really sick is to be determined.

True, and this study isn't really targeting those individuals. This study is done on an outpatient basis, so you get the IV and go home. They are claiming pretty significant reductions in hospitalizations.